Hexahydro-β-acids potently inhibit 12- O -tetradecanoylphorbol 13-acetate-induced skin inflammation and tumor promotion in mice

Chung-Huei Hsu, Yuan-Soon Ho, Ching Shu Lai, Shu Chen Hsieh, Li Hua Chen, Edwin Lin, Chi Tang Ho, Min Hsiung Pan

Research output: Contribution to journalArticle

15 Citations (Scopus)

Abstract

We previously reported that hexahydro-beta-acids (HBAs), reduced derivatives of beta-acids (BA) from hop (Humulus lupulus L.), displayed more potent anti-inflammatory activity than BA in lipopolysaccharide-stimulated murine macrophages. In this study, we investigated the effects and underlying molecular mechanisms of hexahydro-β-acids (HBAs) on 12-O- tetradecanoylphorbol-13-acetate (TPA)-stimulated mouse skin inflammation and in the two-stage carcinogenesis model. Female ICR mice pretreated with HBA at 1 and 10 μg significantly reduced ear edema, epidermal hyperplasia, and infiltration of inflammatory cells caused by TPA. Molecular analysis exhibited that HBA suppressed iNOS, COX-2, and ornithine decarboxylase (ODC) protein and gene expression through interfering with mitogen-activated protein kinases (MAPKs) and phosphatidylinositiol 3-kinase (PI3K)/Akt signaling as well as the activation of transcription factor NF-κB. Furthermore, application of HBA (1 and 10 μg) prior to each TPA treatment (17.2 ± 0.9 tumors/mouse) resulted in the significant reduction of tumor multiplicity (5.1 ± 1.2, P <0.01 and 2.3 ± 1.2, P <0.001, respectively) in 7,12-dimethyl-benzanthracene (DMBA)-initiated mouse skin. The tumor incidence was significantly lowered to 75% (P <0.05) and 58.7% (P <0.01) by HBA pretreatment, respectively, and significantly reduced the tumor weight (0.34 ± 0.14 g, P <0.01 and 0.09 ± 0.10 g, P <0.001, respectively) as compared to DMBA/TPA-induced tumors (0.76 ± 0.04 g).

Original languageEnglish
Pages (from-to)11541-11549
Number of pages9
JournalJournal of Agricultural and Food Chemistry
Volume61
Issue number47
DOIs
Publication statusPublished - Nov 27 2013

Fingerprint

beta acids
Tetradecanoylphorbol Acetate
Tumors
Skin
Acetates
inflammation
acetates
Inflammation
neoplasms
Acids
acids
mice
Neoplasms
Humulus
MAP Kinase Kinase 3
Humulus lupulus
ornithine decarboxylase
hops
Inbred ICR Mouse
Ornithine Decarboxylase

Keywords

  • cyclooxygenase-2 (COX-2)
  • hexahydro-β-acids (HBA)
  • inducible NO synthase (iNOS)
  • inflammation
  • two-stage carcinogenesis

ASJC Scopus subject areas

  • Agricultural and Biological Sciences(all)
  • Chemistry(all)

Cite this

Hexahydro-β-acids potently inhibit 12- O -tetradecanoylphorbol 13-acetate-induced skin inflammation and tumor promotion in mice. / Hsu, Chung-Huei; Ho, Yuan-Soon; Lai, Ching Shu; Hsieh, Shu Chen; Chen, Li Hua; Lin, Edwin; Ho, Chi Tang; Pan, Min Hsiung.

In: Journal of Agricultural and Food Chemistry, Vol. 61, No. 47, 27.11.2013, p. 11541-11549.

Research output: Contribution to journalArticle

Hsu, Chung-Huei ; Ho, Yuan-Soon ; Lai, Ching Shu ; Hsieh, Shu Chen ; Chen, Li Hua ; Lin, Edwin ; Ho, Chi Tang ; Pan, Min Hsiung. / Hexahydro-β-acids potently inhibit 12- O -tetradecanoylphorbol 13-acetate-induced skin inflammation and tumor promotion in mice. In: Journal of Agricultural and Food Chemistry. 2013 ; Vol. 61, No. 47. pp. 11541-11549.
@article{b44af03e7ac94bf688de1b5453b3d17a,
title = "Hexahydro-β-acids potently inhibit 12- O -tetradecanoylphorbol 13-acetate-induced skin inflammation and tumor promotion in mice",
abstract = "We previously reported that hexahydro-beta-acids (HBAs), reduced derivatives of beta-acids (BA) from hop (Humulus lupulus L.), displayed more potent anti-inflammatory activity than BA in lipopolysaccharide-stimulated murine macrophages. In this study, we investigated the effects and underlying molecular mechanisms of hexahydro-β-acids (HBAs) on 12-O- tetradecanoylphorbol-13-acetate (TPA)-stimulated mouse skin inflammation and in the two-stage carcinogenesis model. Female ICR mice pretreated with HBA at 1 and 10 μg significantly reduced ear edema, epidermal hyperplasia, and infiltration of inflammatory cells caused by TPA. Molecular analysis exhibited that HBA suppressed iNOS, COX-2, and ornithine decarboxylase (ODC) protein and gene expression through interfering with mitogen-activated protein kinases (MAPKs) and phosphatidylinositiol 3-kinase (PI3K)/Akt signaling as well as the activation of transcription factor NF-κB. Furthermore, application of HBA (1 and 10 μg) prior to each TPA treatment (17.2 ± 0.9 tumors/mouse) resulted in the significant reduction of tumor multiplicity (5.1 ± 1.2, P <0.01 and 2.3 ± 1.2, P <0.001, respectively) in 7,12-dimethyl-benzanthracene (DMBA)-initiated mouse skin. The tumor incidence was significantly lowered to 75{\%} (P <0.05) and 58.7{\%} (P <0.01) by HBA pretreatment, respectively, and significantly reduced the tumor weight (0.34 ± 0.14 g, P <0.01 and 0.09 ± 0.10 g, P <0.001, respectively) as compared to DMBA/TPA-induced tumors (0.76 ± 0.04 g).",
keywords = "cyclooxygenase-2 (COX-2), hexahydro-β-acids (HBA), inducible NO synthase (iNOS), inflammation, two-stage carcinogenesis",
author = "Chung-Huei Hsu and Yuan-Soon Ho and Lai, {Ching Shu} and Hsieh, {Shu Chen} and Chen, {Li Hua} and Edwin Lin and Ho, {Chi Tang} and Pan, {Min Hsiung}",
year = "2013",
month = "11",
day = "27",
doi = "10.1021/jf403560r",
language = "English",
volume = "61",
pages = "11541--11549",
journal = "Journal of Agricultural and Food Chemistry",
issn = "0021-8561",
publisher = "American Chemical Society",
number = "47",

}

TY - JOUR

T1 - Hexahydro-β-acids potently inhibit 12- O -tetradecanoylphorbol 13-acetate-induced skin inflammation and tumor promotion in mice

AU - Hsu, Chung-Huei

AU - Ho, Yuan-Soon

AU - Lai, Ching Shu

AU - Hsieh, Shu Chen

AU - Chen, Li Hua

AU - Lin, Edwin

AU - Ho, Chi Tang

AU - Pan, Min Hsiung

PY - 2013/11/27

Y1 - 2013/11/27

N2 - We previously reported that hexahydro-beta-acids (HBAs), reduced derivatives of beta-acids (BA) from hop (Humulus lupulus L.), displayed more potent anti-inflammatory activity than BA in lipopolysaccharide-stimulated murine macrophages. In this study, we investigated the effects and underlying molecular mechanisms of hexahydro-β-acids (HBAs) on 12-O- tetradecanoylphorbol-13-acetate (TPA)-stimulated mouse skin inflammation and in the two-stage carcinogenesis model. Female ICR mice pretreated with HBA at 1 and 10 μg significantly reduced ear edema, epidermal hyperplasia, and infiltration of inflammatory cells caused by TPA. Molecular analysis exhibited that HBA suppressed iNOS, COX-2, and ornithine decarboxylase (ODC) protein and gene expression through interfering with mitogen-activated protein kinases (MAPKs) and phosphatidylinositiol 3-kinase (PI3K)/Akt signaling as well as the activation of transcription factor NF-κB. Furthermore, application of HBA (1 and 10 μg) prior to each TPA treatment (17.2 ± 0.9 tumors/mouse) resulted in the significant reduction of tumor multiplicity (5.1 ± 1.2, P <0.01 and 2.3 ± 1.2, P <0.001, respectively) in 7,12-dimethyl-benzanthracene (DMBA)-initiated mouse skin. The tumor incidence was significantly lowered to 75% (P <0.05) and 58.7% (P <0.01) by HBA pretreatment, respectively, and significantly reduced the tumor weight (0.34 ± 0.14 g, P <0.01 and 0.09 ± 0.10 g, P <0.001, respectively) as compared to DMBA/TPA-induced tumors (0.76 ± 0.04 g).

AB - We previously reported that hexahydro-beta-acids (HBAs), reduced derivatives of beta-acids (BA) from hop (Humulus lupulus L.), displayed more potent anti-inflammatory activity than BA in lipopolysaccharide-stimulated murine macrophages. In this study, we investigated the effects and underlying molecular mechanisms of hexahydro-β-acids (HBAs) on 12-O- tetradecanoylphorbol-13-acetate (TPA)-stimulated mouse skin inflammation and in the two-stage carcinogenesis model. Female ICR mice pretreated with HBA at 1 and 10 μg significantly reduced ear edema, epidermal hyperplasia, and infiltration of inflammatory cells caused by TPA. Molecular analysis exhibited that HBA suppressed iNOS, COX-2, and ornithine decarboxylase (ODC) protein and gene expression through interfering with mitogen-activated protein kinases (MAPKs) and phosphatidylinositiol 3-kinase (PI3K)/Akt signaling as well as the activation of transcription factor NF-κB. Furthermore, application of HBA (1 and 10 μg) prior to each TPA treatment (17.2 ± 0.9 tumors/mouse) resulted in the significant reduction of tumor multiplicity (5.1 ± 1.2, P <0.01 and 2.3 ± 1.2, P <0.001, respectively) in 7,12-dimethyl-benzanthracene (DMBA)-initiated mouse skin. The tumor incidence was significantly lowered to 75% (P <0.05) and 58.7% (P <0.01) by HBA pretreatment, respectively, and significantly reduced the tumor weight (0.34 ± 0.14 g, P <0.01 and 0.09 ± 0.10 g, P <0.001, respectively) as compared to DMBA/TPA-induced tumors (0.76 ± 0.04 g).

KW - cyclooxygenase-2 (COX-2)

KW - hexahydro-β-acids (HBA)

KW - inducible NO synthase (iNOS)

KW - inflammation

KW - two-stage carcinogenesis

UR - http://www.scopus.com/inward/record.url?scp=84889844306&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84889844306&partnerID=8YFLogxK

U2 - 10.1021/jf403560r

DO - 10.1021/jf403560r

M3 - Article

C2 - 24206127

AN - SCOPUS:84889844306

VL - 61

SP - 11541

EP - 11549

JO - Journal of Agricultural and Food Chemistry

JF - Journal of Agricultural and Food Chemistry

SN - 0021-8561

IS - 47

ER -